✦ LIBER ✦

Tau oligomers in CSF: A novel biomarker for the diagnosis and evaluation of treatment for Alzheimer's disease and tauopathies

✍ Scribed by Sengupta, Urmi; Portelius, Erik; Castillo-Carranza, Diana; Woltjer, Randy; Galasko, Douglas; Jackson, George; Blennow, Kaj; Kayed, Rakez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSF biomarkers for Alzheimer’s disease:

✍ Blennow, Kaj 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 227 KB

Novel biomarkers for the differential di

✍ Simonsen, Anja H.; Hagnelius, Nils-Olof; Zhang, Fujun; Fung, Eric; Nilsson, Torb 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

CSF biomarker cut-offs for the diagnosis

✍ Julien Dumurgier; François Mouton Liger; Sarah Benisty; Claire Paquet; Pauline L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

O1-4 Identification of a Novel Panel of

✍ Simonsen, A.H.; McGuire, J.; Podust, V.N.; Andreasen, N.; Wallin, A.; Zhang, F.; 📂 Article 📅 2005 🏛 Masson Editeur 🌐 English ⚖ 51 KB

Advances in the development of biomarker

✍ Harald Hampel; Alexander Goernitz; Katharina Buerger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P3-073: CSF Aβ42, Tau and phosphorylated

✍ Herukka, Sanna-Kaisa; Tapiola, Tero; Hallikainen, Merja; Tervo, Susanna; Helisal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB